Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicineJosephine A. Taverna, Chun‐Liang Chen, Meizhen Chen et al.|Lung Cancer|2024Cited by 21
ROS-mediated SRMS activation confers platinum resistance in ovarian cancerYunhan Jiang, Lingtao Jin|Oncogene|2023Cited by 14
<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized MedicineChia‐Nung Hung, Josephine A. Taverna, M. K. Williams et al.|Preprints.org|2023Cited by 0